118 related articles for article (PubMed ID: 8674871)
1. The clinical features and treatment of arteriosclerosis obliterans with diabetes.
Tsushima N; Matsuo H; Hayashi T; Homma S
Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
3. [Arteriosclerosis obliterans (ASO)].
Koshikawa M; Ikeda U
Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
[TBL] [Abstract][Full Text] [Related]
4. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis.
Hoshino J; Ubara Y; Hara S; Sogawa Y; Suwabe T; Higa Y; Nakanishi S; Sawa N; Katori H; Takemoto F; Fujimoto Y; Ohta E; Ohara K; Takaichi K
Circ J; 2007 Aug; 71(8):1193-8. PubMed ID: 17652880
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Ushiyama C; Osada S; Inoue T; Shimada N; Koide H
J Diabetes Complications; 2003; 17(6):349-54. PubMed ID: 14583180
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
7. [Arteriosclerosis obliterans that was improved by LDL apheresis].
Suzuki H; Mutoh E; Kitagawa T; Kubota H; Takasugi Y
Hokkaido Igaku Zasshi; 1993 Jan; 68(1):126-31. PubMed ID: 8444401
[TBL] [Abstract][Full Text] [Related]
8. Arteriosclerosis obliterans in Japanese diabetic patients.
Matsuda A; Kuzuya T
Tohoku J Exp Med; 1983 Dec; 141 Suppl():569-73. PubMed ID: 6680533
[TBL] [Abstract][Full Text] [Related]
9. [Arteriosclerosis obliterans(ASO) in diabetic patients].
Tanaka Y
Nihon Rinsho; 2003 Jul; 61(7):1187-93. PubMed ID: 12877083
[TBL] [Abstract][Full Text] [Related]
10. [Ultrasonographic findings of carotid arteries in female patients with arteriosclerosis obliterans and aortic aneurysm].
Kin K; Iwamoto T; Koyama T; Sugiyama T; Takasaki M
Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):239-44. PubMed ID: 10879074
[TBL] [Abstract][Full Text] [Related]
11. [Arteriosclerosis obliterans].
Kitatani M; Mabuchi H; Ueda K
Nihon Rinsho; 1993 Aug; 51(8):2160-4. PubMed ID: 8411686
[TBL] [Abstract][Full Text] [Related]
12. Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease.
Kawano T; Saito T; Yasu T; Saito T; Nakamura T; Namai K; Tamemoto H; Kawakami M; Saito M; Ishikawa SE
Metabolism; 2005 May; 54(5):653-6. PubMed ID: 15877296
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of sarpogrelate hydrochloride on patients with arteriosclerosis obliterans.
Ren S; Qian S; Wang W; Liu J; Liu P
Ann Thorac Cardiovasc Surg; 2013; 19(1):30-4. PubMed ID: 23364237
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and localizations of obliterating arterial disease of the lower limbs.
Rubba P; Leccia G; Faccenda F; De Simone B; Carbone L; Pauciullo P; Vaccaro O; Mancini M
Angiology; 1991 Apr; 42(4):296-301. PubMed ID: 2014920
[TBL] [Abstract][Full Text] [Related]
16. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: change in prostacyclin and effect on ischemic symptoms.
Mii S; Mori A; Sakata H; Nakayama M; Tsuruta H
Angiology; 1998 Mar; 49(3):175-80. PubMed ID: 9523539
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of arteriosclerosis obliterans of the lower extremity with coronary artery disease].
Hamai K; Hiasa Y; Wada T; Morimoto S; Aihara T; Kataoka Y; Mori H
J Cardiol; 1989 Mar; 19(1):103-12. PubMed ID: 2810031
[TBL] [Abstract][Full Text] [Related]
18. [Early detection and treatment of diseases of the arteries of the legs in patients with diabetes mellitus under ambulatory conditions].
Chukhman BA; Nemudruk NP; Pavliukov VP
Vestn Khir Im I I Grek; 1984 Aug; 133(8):120-2. PubMed ID: 6495512
[TBL] [Abstract][Full Text] [Related]
19. Effects of beraprost sodium (Dorner) in patients with diabetes mellitus complicated by chronic arterial obstruction.
Toyota T; Oikawa S;
Angiology; 2002; 53(1):7-13. PubMed ID: 11863312
[TBL] [Abstract][Full Text] [Related]
20. [Diabetic angiopathies of the legs (clinical aspects, diagnosis and treatment)].
Tikhonova EP; Pavliuchenko RV
Probl Endokrinol (Mosk); 1987; 33(6):88-93. PubMed ID: 3325974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
